Syncom Formulations (India) Balance Sheet Health
Financial Health criteria checks 4/6
Syncom Formulations (India) has a total shareholder equity of ₹2.9B and total debt of ₹724.9M, which brings its debt-to-equity ratio to 25.2%. Its total assets and total liabilities are ₹4.0B and ₹1.2B respectively. Syncom Formulations (India)'s EBIT is ₹287.2M making its interest coverage ratio 7.7. It has cash and short-term investments of ₹1.3B.
Key information
25.2%
Debt to equity ratio
₹724.87m
Debt
| Interest coverage ratio | 7.7x |
| Cash | ₹1.32b |
| Equity | ₹2.88b |
| Total liabilities | ₹1.17b |
| Total assets | ₹4.05b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 524470's short term assets (₹2.7B) exceed its short term liabilities (₹1.1B).
Long Term Liabilities: 524470's short term assets (₹2.7B) exceed its long term liabilities (₹100.0M).
Debt to Equity History and Analysis
Debt Level: 524470 has more cash than its total debt.
Reducing Debt: 524470's debt to equity ratio has increased from 6.5% to 25.2% over the past 5 years.
Debt Coverage: 524470's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 524470's interest payments on its debt are well covered by EBIT (7.7x coverage).